Astra Pharmaceuticals
Astra is a global pharmaceutical company founded in 1913 and headquartered in Södertälje, Sweden.The company is engaged in the research, development, manufacture, and marketing of pharmaceutical products, which are organized into the following four main categories: digestive, cardiovascular, respiratory, and pain relief. It also has some products in the central nervous area. The company also markets other products such as anti-infectives. The subsidiary, Astra Technologies, is engaged in the manufacture and sale of medical devices.
Major products at the time of the merger
Digestive drugs: losec ® (omeprazole) - the world's largest-selling drug Cardiovascular drugs: bethanechol ® (metoprolol tartrate), poitidine ® (felodipine), Ramace ® (Ramipril) and Atacand ® (dihydroclonidine) Respiratory drugs: pramipexole ® (budesonide), Boliconi ® (terbutaline sulphate), Ranocort ® (budesonide), and inhalant propulsion devices Anesthetic drugs: Seroquel ® (lidocaine) - the world's largest-selling local anesthetic
Results for 1998
Total sales of SEK 57 billion Profit of SEK 16 billion Research and development expenses of SEK 10.6 billion Total global workforce of 22,000< /p>
Gericom Group plc
On June 1, 1993, Imperial Chemical Industries Limited (ICI, founded in 1926) spun off three of its businesses (Pharmaceuticals, Agrochemicals and Specialties) to form an independent company, Gericom. Headquartered in London, UK, Gerichem is engaged in the research, development, manufacture and marketing of pharmaceuticals, agrochemicals and specialty chemicals. In pharmaceuticals it focuses on the therapeutic areas of cancer, cardiovascular, central nervous system, respiratory and anesthesia. Jellicam invests heavily in research and development, has a broad international market presence, a strong marketing team, and a solid public **** science base.
Major products at the time of the merger
Oncology drugs: Nolvadex ® (goserelin acetate), Comstock ® (bicalutamide), Nolvadex ® (tamoxifen citrate), and Ranindex ® (anastrozole) Cardiovascular drugs: Gemchem &. reg; (Lenopril) and Tenormin ® (Atenolol) Respiratory drugs: Encore ® (Zalustat) CNS drugs: Zomig ® (Zolmitriptan) Anesthesia drugs: Depo-Proximat ® (Propofol), the world's largest-selling injectable conventional anesthesia Agrochemicals: Gramoxone ® (Zanzaparin), the world's largest-selling injectable conventional anesthesia drug. Agrochemicals: Gramoxone®, Fusilade®, Touchdown® and Surpass® (herbicides); Karate® (insecticides); and Amistar® (fungicides)
Results in 1998
Group sales
The Group's total sales were as follows p>
Group gross sales of ￡5.5 billion Operating income of over ￡1 billion Research and development costs of ￡602 million Total global workforce of 34,000